Anvisa authorizes the importation of raw material for the Butantan vaccine; SP says production will be delayed 20 days – 10/28/2020 – Balance and health

[ad_1] Anvisa (National Health Surveillance Agency) authorized on Wednesday (28) the importation, on an exceptional basis, of raw material that must be used in the production of vaccines against Covid-19 by the Butantan Institute. The material will be imported from the Chinese company Sinovac, which has a partnership with Butantan …

Read More »